HIV 1 News and Research

RSS

WHO's new data reveals high levels of antibiotic resistance worldwide

WHO's first release of surveillance data on antibiotic resistance reveals high levels of resistance to a number of serious bacterial infections in both high- and low-income countries.

4 Jun 2020

A tailored public health approach could guide the next phase of COVID-19 pandemic

A tailored public health approach that accounts for variation in risks across populations, places and time could guide the next phase of Canada's coronavirus disease 2019 (COVID-19) response, argue authors in a commentary in CMAJ.

3 Jun 2020

New COVID-19 test speeds up access to urgent care

The first analysis of a new point-of-care "nucleic acid test" for SARS-CoV-2 in a UK hospital setting shows these machines dramatically reduce time spent on COVID-19 'holding' wards - allowing patients to be treated or discharged far quicker than with current lab testing set-ups.

3 Jun 2020

Is it safe for SARS-CoV-2 positive mothers to breastfeed?

Even as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus continues to cause thousands of cases every day, with many deaths, life continues to move on regardless. Births occur as usual, and in many countries, mothers prefer to breastfeed their babies, at least for the first few months of life.

2 Jun 2020

Studies call for reforms to improve nutritional programs in HIV care settings

HIV management in developing countries varies with socioeconomic and structural circumstances, with two Flinders University studies finding examples of key ways to close the gap for those worst affected in developing countries.

1 Jun 2020

Democratic super PAC uses familiar political play to hit Trump on Medicare

Priorities USA Action, a Democratic super PAC, announced a new digital and TV ad series criticizing President Donald Trump's response to the coronavirus pandemic.

1 Jun 2020

How COVID-19 affects the nervous system

A new paper published in the journal JAMA Neurology in May 2020 discusses the presentation and complications of COVID-19 with respect to the nervous system.

31 May 2020

Scientists discover two anti-inflammatory drugs that inhibit COVID-19 infection

Since the outbreak of the COVID-19 pandemic and its rapid spread, the scientific community has been working on developing an effective treatment for the virus responsible for the disease.

27 May 2020

Study: High level of anxiety is linked to depression

Led by King's College London in collaboration with the University of Zimbabwe and the London School of Hygiene & Tropical Medicine, and published in The Lancet's EClinicalMedicine journal, the research examined a group of people with depression in Zimbabwe and found that people are nearly three times more likely to suffer this illness long-term if they also have a high level of anxiety.

27 May 2020

New strategy identified to address the underlying cause of LAD1 patients' symptoms

Owing to a rare genetic mutation, individuals with leukocyte adhesion deficiency type 1 (LAD1) experience a suite of symptoms that trace back to an immune system dysfunction.

27 May 2020

EKF secures COVID-19 novel sample collection kit manufacturing and supply contracts

EKF Diagnostics, the global in vitro diagnostics company, announces it has secured new contracts for the manufacture and supply of a novel, patented sample collection device which allows COVID-19 samples to be rapidly inactivated in the collection tube, avoiding contamination and preserving RNA without need for refrigeration.

From EKF Diagnostics 26 May 2020

Can Chlorpromazine help treat COVID-19?

A new research paper published in the journal L'Encéphale in May 2020 reports on the planned ReCoVery Study, which will examine the possibility of repurposing the antipsychotic drug chlorpromazine for the treatment of COVID-19.

25 May 2020

Reopening dental offices for routine care amid pandemic touches a nerve

Tom Peeling wanted his teeth cleaned and wasn't going to let the coronavirus pandemic get in the way.

21 May 2020

Scientist has ‘invisible enemy’ in sights with microscopic portraits of coronavirus

From her laboratory in the far western reaches of Montana, Elizabeth Fischer is trying to help people see what they're up against in COVID-19.

21 May 2020

Lifesaving innovation for COVID-19 will increase the already existing racial inequalities

As is the case with most fatal diseases, coronavirus disease (COVID-19) is already taking a disproportionate toll on black Americans and other disadvantaged minorities.

20 May 2020

Study shows engineered SARS-CoV-2 spike protein may be utilized for vaccine development

In a new study available on the preprint server bioRxiv, researchers demonstrate how the conformation of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S-protein) can be controlled with the rational construct design, providing a framework for S-protein structure engineering in vaccine/drug development.

20 May 2020

African American communities more burdened by COVID-19, say researchers

A new study conducted by researchers at Florida International University, Miami, has found that communities in the United States with a high density of African Americans are disproportionately burdened with the adverse outcomes of coronavirus disease 2019 (COVID-19).

20 May 2020

Does COVID-19 infect peripheral blood cells?

The emergence of the novel coronavirus outbreak in December 2019 was followed by its spread on a global scale unparalleled in the last 100 years. At present, it has claimed over 322,000 lives the world over, with over 4.88 million cases having tested positive.

19 May 2020

Three FDA-approved drugs can block the replication of COVID-19 virus

Three drugs that are already approved by the Food and Drug Administration (FDA) or other international agencies can block the production of the novel coronavirus that causes COVID-19 in human cells, according to computational and pharmaceutical studies performed by UT Southwestern scientists.

19 May 2020

Global study to test whether antimalaria drug can prevent COVID-19 in health-care workers

With $9 million in philanthropic support, an international group of physicians and scientists is establishing a research network to evaluate promising therapies for COVID-19.

18 May 2020

HIV 1 News and Research

WHO's new data reveals high levels of antibiotic resistance worldwide

A tailored public health approach could guide the next phase of COVID-19 pandemic

New COVID-19 test speeds up access to urgent care

Is it safe for SARS-CoV-2 positive mothers to breastfeed?

Studies call for reforms to improve nutritional programs in HIV care settings

Democratic super PAC uses familiar political play to hit Trump on Medicare

How COVID-19 affects the nervous system

Scientists discover two anti-inflammatory drugs that inhibit COVID-19 infection

Study: High level of anxiety is linked to depression

New strategy identified to address the underlying cause of LAD1 patients' symptoms

EKF secures COVID-19 novel sample collection kit manufacturing and supply contracts

Can Chlorpromazine help treat COVID-19?

Reopening dental offices for routine care amid pandemic touches a nerve

Scientist has ‘invisible enemy’ in sights with microscopic portraits of coronavirus

Lifesaving innovation for COVID-19 will increase the already existing racial inequalities

Study shows engineered SARS-CoV-2 spike protein may be utilized for vaccine development

African American communities more burdened by COVID-19, say researchers

Does COVID-19 infect peripheral blood cells?

Three FDA-approved drugs can block the replication of COVID-19 virus

Global study to test whether antimalaria drug can prevent COVID-19 in health-care workers

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News